Korea's Alteogen inks $365 M deal for development and commercialisation of Hybrozyme™-enabled subcutaneous biologic product

Alteogen Inc., a South Korea-based biopharmaceutical company specialising in platform technologies, has entered into an ...

August 6, 2026 | Thursday | News
Most of Asia's Pharma Trade Is Sheltered From the US Tariff. That Is Exactly Why You Should Worry.

On 29 September, the second compliance date under Proclamation 11020 arrives. From that moment, every pharmaceutical imp...

August 6, 2026 | Thursday | Analysis
China's AsymBio secures $184 M capital injection to support long-term growth

AsymBio, a China-based biologics-focused Contract Development and Manufacturing Organization (CDMO) and a subsidiary of ...

August 5, 2026 | Wednesday | News
Korea's medtech firm Ainex Corporation inks deal with Singapore's National University Hospital

South Korea-based Ainex Corporation, a medical AI company specialising in gastrointestinal endoscopy, has signed an agre...

August 5, 2026 | Wednesday | News
Japan's Fujifilm and Taiho Pharma join hands to develop next-generation ADC manufacturing technologies

Fujifilm Corporation and Taiho Pharmaceutical have entered into a strategic partnership agreement for the development of...

August 5, 2026 | Wednesday | News
American biotech startup CREATE Medicines inks license agreement with Australia's Monash University

CREATE Medicines, Inc., a US-based clinical-stage biotechnology company pioneering in vivo immune programming, has annou...

August 1, 2026 | Saturday | News
“Emerging economies continue to face a substantial burden of rheumatic heart disease”

RESILIA tissue has been positioned as a significant advancement in valve technology. How does RESILIA tissue differ from...

August 1, 2026 | Saturday | Opinion
The Third Dimension of Antibody Therapy

Bispecific antibodies have transformed treatment by simultaneously targeting two molecules, delivering significant clini...

August 1, 2026 | Saturday | Analysis
Bridging the Rare Disease Access Gap in Asia-Pacific

Although each rare disease affects only a small number of people, collectively they represent one of the world's largest...

August 1, 2026 | Saturday | Analysis
Insilico Medicine launches industry's first drug discovery and development Benchmark as a Service

Hong Kong headquartered Insilico Medicine, a clinical-stage generative artificial intelligence (AI)-driven drug discover...

August 1, 2026 | Saturday | News
Amorepacific Holdings and HIGHER Corporation announce collaboration on beauty and medical aesthetics in Korea

Amorepacific Holdings has signed a strategic investment agreement with Korean startup HIGHER Corporation, a medical aest...

August 1, 2026 | Saturday | News
Ember LifeSciences and Alfresa Corp to improve quality of pharmaceutical cold chain in Japan

Ember LifeSciences, Inc. has entered into a capital and business alliance with Alfresa Corporation, a subsidiary of Alfr...

August 1, 2026 | Saturday | News
Ono Pharmaceutical partners with Phylo to embed agentic AI with every discovery scientist

Japan-based Ono Pharmaceutical and US-based Phylo, Inc. have announced a collaboration that brings Biomni Lab, Phylo's a...

July 30, 2026 | Thursday | News
DKSH Korea expands strategic partnership with Novartis for hypertension treatment

DKSH Business Unit Healthcare, a strategic healthcare solutions partner and leading provider of Market Expansion Service...

July 30, 2026 | Thursday | News
Australian startup Navi raises $A6.8 M to commercialise breakthrough paediatric technology in US

Melbourne- and Boston-based medical device company Navi Medical Technologies has closed a $A6.8 million capital raise to...

July 29, 2026 | Wednesday | News
BioSpectrum Asia launches the APAC Bioeconomy Index 2026, the region's first independent value-journey benchmark

BioSpectrum Asia launched the APAC Bioeconomy Index 2026, the first independent, region-native benchmark of Asia-Pacific...

July 29, 2026 | Wednesday | Analysis
Single-Use Bioreactors Are Redefining Asia's Next Generation of Biomanufacturing

Asia's biopharmaceutical manufacturing sector is entering a new phase of growth, driven by expanding biologics pipelines...

July 29, 2026 | Wednesday | Influencers
AsymBio kicks off construction of R&D building in China for biologics services

AsymBio, a biologics-focused Contract Development and Manufacturing Organization (CDMO) and a subsidiary of Asymche...

July 29, 2026 | Wednesday | News
Eppendorf injects EUR 40 M into new production site in Penang, Malaysia

The globally active life science company Eppendorf SE is taking the next major step in expanding its international manuf...

July 29, 2026 | Wednesday | News
Nippon Kayaku and Celltrion Healthcare Japan join hands for stable supply of biopharmaceuticals

Nippon Kayaku and Celltrion Healthcare Japan K.K. have entered into a Memorandum of Understanding (MoU) on Compreh...

July 29, 2026 | Wednesday | News
Harbour BioMed and Sinopharm enter strategic collaboration to establish innovation R&D consortium

Harbour BioMed, a US-based biopharmaceutical company, has entered into a strategic collaboration with China Nationa...

July 28, 2026 | Tuesday | News
Waters launches Xevo TQ Absolute XR IVD Mass Spectrometer

US-based Waters Corporation has announced the launch of the Xevo TQ Absolute XR IVD Mass Spectrometer, expanding it...

July 28, 2026 | Tuesday | News
HoneyNaps registers as CRO with Korea National Enterprise for Clinical Trials

HoneyNaps has officially registered as a Contract Research Organization (CRO) with the Korea National Enterprise for Cli...

July 28, 2026 | Tuesday | News
Orbiva inks MoU with Articura to advance digital health ecosystem in Indonesia

Hong Kong-based Home Control International has announced that its wholly-owned subsidiary, Orbiva has entered into ...

July 27, 2026 | Monday | News
Shimadzu releases GCMS-TQ RX Series Gas Chromatograph-Mass Spectrometer

Japan-based Shimadzu Corporation has announced the release of the GCMS-TQ8040 RX and GCMS-TQ8050 RX gas chromatogra...

July 27, 2026 | Monday | News